![Paula Boultbee: Join me in raising awareness and advocating for equitable treatment options worldwide](https://oncodaily.com/pub/uploads/2024/09/Untitled-design-1-1280x960.jpg)
Paula Boultbee: Join me in raising awareness and advocating for equitable treatment options worldwide
Paula Boultbee shared on LinkedIn:
“Today, I’m honored to share a special message from Dr. Karen Meliksetyan, a dedicated hematologist in Armenia. As a board member of The Max Foundation, I had the privilege of meeting Dr. Karen during his visit to the US this past spring and was inspired by his commitment to improving the lives of those living with blood diseases such as Chronic Lymphocytic Leukemia (CLL).
The stories from those on the frontlines of healthcare can be incredibly inspiring.
Dr. Karen has said, ‘For many years, the treatment of blood cancer, particularly CLL, has posed and continues to pose a significant challenge in Armenia. Not only are these medications costly, but they are also often unlicensed and unavailable within the country.’
Join me in raising awareness and advocating for equitable treatment options worldwide.”
Source: Paula Boultbee/LinkedIn
Paula Boultbee is a member of the Board of Directors at The Max Foundation. He is the Owner of PTB consulting LLC. Previously, he has served as a Board Member at ISOFOL Medical AB. Previously, she served as the Chief Commercial Officer at Oncopeptides.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023